- 現金殖利率: N/A、總殖利率: 0、5年平均現金配發率: N/A
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | 0.13 | -69.77 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2022 (9) | 0.43 | 59.26 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2021 (8) | 0.27 | -44.9 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2020 (7) | 0.49 | -15.52 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2019 (6) | 0.58 | -32.56 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2018 (5) | 0.86 | 36.51 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2017 (4) | 0.63 | 600.0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2016 (3) | 0.09 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
---|---|---|---|---|---|---|---|---|---|
24Q3 (20) | 0.13 | -31.58 | 116.67 | 0.14 | -17.65 | 1500.0 | 0.49 | 36.11 | 716.67 |
24Q2 (19) | 0.19 | 18.75 | 2000.0 | 0.17 | 41.67 | 666.67 | 0.36 | 125.0 | 0 |
24Q1 (18) | 0.16 | 166.67 | 1500.0 | 0.12 | -20.0 | 300.0 | 0.16 | 23.08 | 1500.0 |
23Q4 (17) | 0.06 | 0.0 | 200.0 | 0.15 | 1600.0 | 275.0 | 0.13 | 116.67 | -69.77 |
23Q3 (16) | 0.06 | 700.0 | -45.45 | -0.01 | 66.67 | -150.0 | 0.06 | 0 | -85.71 |
23Q2 (15) | -0.01 | -200.0 | -105.56 | -0.03 | -200.0 | -127.27 | 0.00 | -100.0 | -100.0 |
23Q1 (14) | 0.01 | -50.0 | -91.67 | 0.03 | -25.0 | -62.5 | 0.01 | -97.67 | -91.67 |
22Q4 (13) | 0.02 | -81.82 | -60.0 | 0.04 | 100.0 | 0.0 | 0.43 | 2.38 | 59.26 |
22Q3 (12) | 0.11 | -38.89 | 57.14 | 0.02 | -81.82 | -66.67 | 0.42 | 35.48 | 90.91 |
22Q2 (11) | 0.18 | 50.0 | 200.0 | 0.11 | 37.5 | 22.22 | 0.31 | 158.33 | 106.67 |
22Q1 (10) | 0.12 | 140.0 | 50.0 | 0.08 | 100.0 | -20.0 | 0.12 | -55.56 | 50.0 |
21Q4 (9) | 0.05 | -28.57 | -28.57 | 0.04 | -33.33 | -66.67 | 0.27 | 22.73 | -44.9 |
21Q3 (8) | 0.07 | 16.67 | -53.33 | 0.06 | -33.33 | -62.5 | 0.22 | 46.67 | -47.62 |
21Q2 (7) | 0.06 | -25.0 | -57.14 | 0.09 | -10.0 | -47.06 | 0.15 | 87.5 | -46.43 |
21Q1 (6) | 0.08 | 14.29 | -42.86 | 0.10 | -16.67 | 0.0 | 0.08 | -83.67 | -42.86 |
20Q4 (5) | 0.07 | -53.33 | -36.36 | 0.12 | -25.0 | -36.84 | 0.49 | 16.67 | -15.52 |
20Q3 (4) | 0.15 | 7.14 | 0.0 | 0.16 | -5.88 | 0.0 | 0.42 | 50.0 | 0.0 |
20Q2 (3) | 0.14 | 0.0 | 0.0 | 0.17 | 70.0 | 0.0 | 0.28 | 100.0 | 0.0 |
20Q1 (2) | 0.14 | 27.27 | 0.0 | 0.10 | -47.37 | 0.0 | 0.14 | -75.86 | 0.0 |
19Q4 (1) | 0.11 | 0.0 | 0.0 | 0.19 | 0.0 | 0.0 | 0.58 | 0.0 | 0.0 |
年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
---|---|---|---|---|---|---|---|---|---|---|
2024/10 | 1.79 | -1.42 | 41.08 | 16.17 | 67.66 | 5.56 | N/A | 本期因產品組合優化,致營收增加。 | ||
2024/9 | 1.81 | -7.37 | 55.57 | 14.38 | 71.68 | 5.52 | 0.83 | 本期因產品組合優化,致營收增加。 | ||
2024/8 | 1.96 | 12.25 | 77.16 | 12.57 | 74.28 | 5.22 | 0.88 | 本期因產品組合優化,致營收增加。 | ||
2024/7 | 1.74 | 14.63 | 112.99 | 10.61 | 73.76 | 4.79 | 0.96 | 去年同期受國際情勢及市場需要疲弱等因素影響,致營收基期較低;及本期因產品組合優化,致營收增加。 | ||
2024/6 | 1.52 | -0.08 | 83.72 | 8.86 | 67.69 | 4.54 | 1.09 | 去年同期受國際情勢及市場需要疲弱等因素影響,致營收基期較低;及本期因產品組合優化,致營收增加。 | ||
2024/5 | 1.52 | 1.94 | 74.36 | 7.34 | 64.71 | 4.73 | 1.04 | 去年同期受國際情勢及市場需要疲弱等因素影響,致營收基期較低;及本期因產品組合優化,致營收增加。 | ||
2024/4 | 1.49 | -12.87 | 91.0 | 5.82 | 62.36 | 4.49 | 1.1 | 去年同期受國際情勢及市場需要疲弱等因素影響,致營收基期較低;及本期因產品組合優化,致營收增加。 | ||
2024/3 | 1.71 | 33.36 | 138.38 | 4.33 | 54.37 | 4.33 | 1.14 | 去年同期受國際情勢及市場需要疲弱等因素影響,致營收基期較低;及本期因產品組合優化,致營收增加。 | ||
2024/2 | 1.29 | -3.12 | 29.89 | 2.61 | 25.37 | 4.0 | 1.23 | - | ||
2024/1 | 1.33 | -4.37 | 21.28 | 1.33 | 21.28 | 4.01 | 1.23 | - | ||
2023/12 | 1.39 | 7.47 | 11.14 | 12.32 | -7.7 | 3.95 | 1.27 | - | ||
2023/11 | 1.29 | 1.9 | 16.81 | 10.93 | -9.64 | 3.72 | 1.35 | - | ||
2023/10 | 1.27 | 8.7 | 19.93 | 9.64 | -12.3 | 3.54 | 1.42 | - | ||
2023/9 | 1.17 | 5.47 | 16.32 | 8.38 | -15.73 | 3.09 | 1.59 | - | ||
2023/8 | 1.11 | 34.96 | 17.89 | 7.21 | -19.32 | 2.75 | 1.78 | - | ||
2023/7 | 0.82 | -1.12 | -10.26 | 6.11 | -23.68 | 2.52 | 1.94 | - | ||
2023/6 | 0.83 | -5.16 | -25.43 | 5.29 | -25.41 | 2.48 | 1.95 | - | ||
2023/5 | 0.87 | 11.66 | -31.93 | 4.46 | -25.41 | 2.37 | 2.04 | - | ||
2023/4 | 0.78 | 8.73 | -40.45 | 3.58 | -23.62 | 2.49 | 1.94 | - | ||
2023/3 | 0.72 | -27.32 | -39.28 | 2.8 | -17.09 | 2.8 | 1.58 | - | ||
2023/2 | 0.99 | -9.54 | -12.48 | 2.08 | -5.12 | 3.33 | 1.33 | - | ||
2023/1 | 1.09 | -12.36 | 2.68 | 1.09 | 2.68 | 3.45 | 1.28 | - | ||
2022/12 | 1.25 | 12.95 | 17.39 | 13.35 | -4.91 | 3.41 | 1.16 | - | ||
2022/11 | 1.11 | 4.62 | -2.14 | 12.1 | -6.73 | 3.16 | 1.25 | - | ||
2022/10 | 1.06 | 5.42 | 4.06 | 11.0 | -7.17 | 3.0 | 1.33 | - | ||
2022/9 | 1.0 | 6.9 | -10.91 | 9.94 | -8.23 | 2.85 | 1.52 | - | ||
2022/8 | 0.94 | 2.71 | -23.24 | 8.94 | -7.92 | 2.96 | 1.46 | - | ||
2022/7 | 0.91 | -17.84 | -23.17 | 8.0 | -5.71 | 3.31 | 1.31 | - | ||
2022/6 | 1.11 | -13.43 | -5.59 | 7.09 | -2.87 | 3.71 | 1.02 | - | ||
2022/5 | 1.28 | -2.31 | 10.69 | 5.98 | -2.34 | 3.78 | 1.0 | - | ||
2022/4 | 1.31 | 10.87 | 4.83 | 4.69 | -5.39 | 3.63 | 1.04 | - | ||
2022/3 | 1.18 | 4.75 | -13.11 | 3.38 | -8.85 | 3.38 | 1.08 | - | ||
2022/2 | 1.13 | 6.13 | -4.79 | 2.2 | -6.37 | 3.26 | 1.12 | - | ||
2022/1 | 1.07 | 0.17 | -7.99 | 1.07 | -7.99 | 3.26 | 1.12 | - | ||
2021/12 | 1.06 | -5.84 | -24.55 | 14.04 | -3.18 | 3.21 | 1.05 | - | ||
2021/11 | 1.13 | 11.26 | -1.68 | 12.98 | -0.88 | 3.27 | 1.03 | - | ||
2021/10 | 1.02 | -9.75 | -19.29 | 11.85 | -0.8 | 3.36 | 1.01 | - | ||
2021/9 | 1.12 | -7.88 | -13.71 | 10.83 | 1.36 | 3.53 | 0.87 | - | ||
2021/8 | 1.22 | 2.8 | 10.02 | 9.71 | 3.46 | 3.59 | 0.85 | - | ||
2021/7 | 1.19 | 0.96 | 3.54 | 8.49 | 2.58 | 3.52 | 0.87 | - | ||
2021/6 | 1.18 | 1.5 | 1.8 | 7.3 | 2.42 | 3.59 | 0.81 | - | ||
2021/5 | 1.16 | -7.48 | 1.39 | 6.12 | 2.54 | 3.78 | 0.77 | - | ||
2021/4 | 1.25 | -8.1 | -6.21 | 4.96 | 2.82 | 3.8 | 0.77 | - | ||
2021/3 | 1.36 | 14.78 | 8.6 | 3.71 | 6.28 | 3.71 | 0.74 | - | ||
2021/2 | 1.19 | 2.57 | 9.32 | 2.35 | 4.98 | 3.76 | 0.73 | - | ||
2021/1 | 1.16 | -17.85 | 0.86 | 1.16 | 0.86 | 3.72 | 0.73 | - | ||
2020/12 | 1.41 | 22.7 | 21.15 | 14.5 | -1.99 | 3.82 | 0.76 | - | ||
2020/11 | 1.15 | -8.65 | -13.97 | 13.09 | -3.97 | 3.71 | 0.78 | - | ||
2020/10 | 1.26 | -3.51 | -4.87 | 11.94 | -2.88 | 3.67 | 0.79 | - | ||
2020/9 | 1.3 | 17.45 | -1.5 | 10.68 | -2.65 | 3.56 | 1.02 | - | ||
2020/8 | 1.11 | -3.24 | -16.76 | 9.38 | -2.8 | 3.41 | 1.06 | - | ||
2020/7 | 1.15 | -0.73 | -14.73 | 8.27 | -0.57 | 3.45 | 1.05 | - | ||
2020/6 | 1.16 | 1.09 | 2.4 | 7.12 | 2.16 | 3.63 | 0.93 | - | ||
2020/5 | 1.14 | -14.42 | -2.94 | 5.97 | 2.11 | 3.73 | 0.9 | - | ||
2020/4 | 1.34 | 6.41 | 10.27 | 4.83 | 3.39 | 3.68 | 0.92 | - | ||
2020/3 | 1.26 | 15.55 | 12.33 | 3.49 | 0.97 | 3.49 | 1.0 | - | ||
2020/2 | 1.09 | -5.36 | -1.35 | 2.23 | -4.45 | 3.4 | 1.03 | - | ||
2020/1 | 1.15 | -1.33 | -7.2 | 1.15 | -7.2 | 3.65 | 0.96 | - | ||
2019/12 | 1.16 | -12.87 | -0.66 | 14.8 | -8.99 | 0.0 | N/A | - | ||
2019/11 | 1.34 | 1.0 | 15.36 | 13.63 | -9.63 | 0.0 | N/A | - |